2001 (v1)
Publication
BACKGROUND AND PURPOSE. Donepezil, an acetylcolinesterase inibitor, is one of the main current therapeutic approach to Alzheimer's disease (AD). Modest but significant clinical and neuropsychological effects have been documented in a part of patients by longitudinal studies versus placebo. Despite these relevant effects on a previously...
Uploaded on: April 14, 2023